-
BDA's seven enterprises selected as national-level maker spaces
2021-04-16
The Torch Center of the Ministry of Science and Technology has announced that 2,251 "maker spaces" are eligible for national recognition in 2020.
-
Q1 foreign investment tops 300b yuan, ministry says
2021-04-16
China will remain increasingly attractive to foreign investment, as the world's second-largest economy continuously improves its business environment and expands its domestic market under the dual circulation development paradigm, according to experts and business leaders.
-
MAH system reaches BDA
2021-04-15
After the drug marketing authorization holder system (MAH) takes effect in China, market entities with drug technology but no production plants can also apply for a drug marketing license and obtain drug marketing license approvals.
-
Hydrogen power injected into BDA's auto industry
2021-04-15
On April 7, the Beijing Municipal Bureau of Economy and Information Technology solicited opinions from the general public on the "Implementation Plan on the Industrial Development of Hydrogen Energy in Beijing (2021-2025)".
-
BDA bathed in spring
2021-04-15
No matter where you live, you can see parks after 500 meters of walking, and encounter rivers within a one kilometer distance.
-
Sanofi setting up its 1st research institute in China
2021-04-15
French pharmaceutical company Sanofi announced the establishment of Sanofi Institute for Biomedical Research, its first global research institute in China, in Suzhou, Jiangsu province, neighboring Shanghai on Tuesday.
-
NielsenIQ, JD.com forge data cooperation
2021-04-15
Leading measurement and data analytics company NiesenIQ and JD's online supermarket JD Super and JD Retail Cloud teamed up on Thursday to embark on comprehensive data cooperation, launching a new partnership to help brand owners and retailers in fast-moving consumer goods build effective online operation strategies, sustain high brand performance and make informed decisions.
-
Bayer transforms pharma business through breakthrough innovation in healthcare
2021-04-15
At its recent virtual media event on January 13th 2021, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are currently still difficult to treat. The company has recently heavily invested in external innovation with an unprecedented number of more than 25 collaboration agreements and acquisitions.